GoodRx Holdings, Inc. is a health information services business based in the US. GoodRx shares (GDRX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $50.14 – a decrease of 3.82% over the previous week. GoodRx employs 338 staff and has a trailing 12-month revenue of around $471.7 million.
|Latest market close||$50.14|
|52-week range||$45.5 - $64.219|
|50-day moving average||$52.9497|
|200-day moving average||$52.9497|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2021-01-15)||16.88%|
|1 month (2020-12-23)||5.36%|
|3 months (2020-10-23)||-4.50%|
Valuing GoodRx stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of GoodRx's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
GoodRx's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 217x. In other words, GoodRx shares trade at around 217x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
GoodRx's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$176.4 million.
The EBITDA is a measure of a GoodRx's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$471.7 million|
|Operating margin TTM||34.23%|
|Gross profit TTM||USD$374.2 million|
|Return on assets TTM||0%|
|Return on equity TTM||0%|
|Market capitalisation||USD$19.9 billion|
TTM: trailing 12 months
There are currently 1.9 million GoodRx shares held short by investors – that's known as GoodRx's "short interest". This figure is up from 0 last month.
There are a few different ways that this level of interest in shorting GoodRx shares can be evaluated.
GoodRx's "short interest ratio" (SIR) is the quantity of GoodRx shares currently shorted divided by the average quantity of GoodRx shares traded daily (recently around 8.7 million). GoodRx's SIR currently stands at 0.22. In other words for every 100,000 GoodRx shares traded daily on the market, roughly 220 shares are currently held short.
However GoodRx's short interest can also be evaluated against the total number of GoodRx shares, or, against the total number of tradable GoodRx shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case GoodRx's short interest could be expressed as 0% of the outstanding shares (for every 100,000 GoodRx shares in existence, roughly 0 shares are currently held short) or 0.0449% of the tradable shares (for every 100,000 tradable GoodRx shares, roughly 45 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against GoodRx.
Find out more about how you can short GoodRx stock.
We're not expecting GoodRx to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
GoodRx Holdings, Inc. is a holding company. The company, through its subsidiaries, owns and operates a prescription drug price comparison platform using data from local and mail-order pharmacies in the United States. It also provides pharmacy coupons to customers. The company offers generic and brand name pricing; alerts clients on manufacturer co-pay cards, pharmacy discounts, and state discount programs; and provides tips on slashing drug prices. It provides prices of drugs in areas of alcohol dependence, allergies, cold, Alzheimer's disease, angina, antibiotics, anticoagulant, antiviral, antiplatelet, anxiety, arrhythmia, arrhythmia, asthma, bipolar disorder, birth control, cancer, cerebral hemorrhage, cholesterol, COPD, depression, dermatology, diabetes, ear, enlarged prostate, epilepsy, eye, fertility, fibromyalgia, flu, gastrointestinal, heart failure, hypertension, hypotension, immune system, insomnia, medical supplies, men's health, mental health, migraine, myasthenia gravis, nausea, nervous system, obesity, obsessive-compulsive disorder, opioid dependence, pain relief, arthritis, panic disorder, Parkinson's disease, PMDD, restless leg syndrome, schizophrenia, seizure, sleep aids, smoking and addiction, smoking cessation, thyroid drugs, Tourette syndrome, trazodone, urology, vaccines, and women's health. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.
Steps to owning and managing 17 Education & Technology Group stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing StealthGas stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing Enterprise Products stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing DXC stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing Bionano Genomics stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing Sunrun stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing PLDT stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing Oxford Lane Capital stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing NetEase stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing Gulfport Energy stocks, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.